BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 26408257)

  • 1. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
    Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
    J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
    Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
    J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
    Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
    Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
    Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
    Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
    Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
    Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.
    Garcia A; Desrosiers L; Scollon S; Gruner S; Reuther J; Gandhi I; Patil N; Fuller MY; Dai H; Muzny D; Gibbs RA; Bercaw-Pratt JL; Rao SL; Rainusso N; Fisher KE; Lin FY; Plon SE; Parsons DW; Roy A
    Cancer Genet; 2022 Apr; 262-263():53-56. PubMed ID: 35026696
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
    Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame
    Apellaniz-Ruiz M; de Kock L; Sabbaghian N; Guaraldi F; Ghizzoni L; Beccuti G; Foulkes WD
    Eur J Endocrinol; 2018 Feb; 178(2):K11-K19. PubMed ID: 29187512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
    Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
    JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
    Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
    Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
    Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.
    Klein S; Lee H; Ghahremani S; Kempert P; Ischander M; Teitell MA; Nelson SF; Martinez-Agosto JA
    J Med Genet; 2014 May; 51(5):294-302. PubMed ID: 24676357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of
    Golmard L; Vasta LM; Duflos V; Corsini C; Dubois d'Enghien C; McMaster ML; Harney LA; Carr AG; Ling A; Dijoud F; Gauthier A; Miettinen M; Cost NG; Gauthier-Villars M; Orbach D; Irtan S; Haouy S; Schultz KA; Stoppa-Lyonnet D; Coupier I; Stewart DR; Sirvent N
    J Med Genet; 2022 Apr; 59(4):346-350. PubMed ID: 33782093
    [No Abstract]   [Full Text] [Related]  

  • 18. A family with Sertoli-Leydig cell tumour, multinodular goiter, and
    Haley M; Bindal P; McAuliffe A; Vredenburgh J
    Curr Oncol; 2019 Jun; 26(3):183-185. PubMed ID: 31285663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
    Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
    Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome.
    de Kock L; Druker H; Weber E; Hamel N; Traubici J; Malkin D; Arseneau J; Stewart CJ; Bouron-Dal Soglio D; Priest JR; Foulkes WD
    Hum Pathol; 2015 Jun; 46(6):917-22. PubMed ID: 25836323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.